Long-term vascular access for hemodialysis using silicon dual-lumen catheters with guidewire replacement of catheters for technique salvage

Difficulties in creating vascular access in patients on hemodialysis are encountered in most dialysis centers, This is usually due to a lack of suitable peripheral vessels due to previous access surgery in patients on longterm hemodialysis, but also may be seen in some patients de novo, particularly diabetics and patients with peripheral vascular disease, Surgical techniques used to overcome this problem vary depending on patient characteristics and, to a certain extent, on local expertise/preference. We report our experience of using silicon dual-lumen hemodialysis catheters over a 3-year period; during this time, 54 catheters were inserted into 32 hemodialysis patients, The indication for this procedure in 52 catheters (31 patients) was either exhausted vascular access or obvious difficulty identifying a suitable peripheral blood vessel, Of the catheters inserted, 20 were placed into subclavian veins by primary insertion (ie, patients did not have existing subclavian catheter); 34 were replaced over a guidewire (a procedure used to allow technique salvage), The catheter survival rate was 72.7% at 90 days and 48.7% at 1 year, Corresponding rates at 90 days and 1 year for technique survival were 93.3% and 81.8%, respectively, The mean catheter and technique survival was 387 (95% confidence intervals [Cls], 273, 502) and 844 (95% Cls, 684, 1,005) days, respectively, Poor flow accounted for 70.4% of catheter failures and, despite 18 episodes of catheter-related sepsis, no catheters were lost due to infection, Factors identified as leading to reduced catheter survival were left-sided placement and catheter tip placement in the superior vena cava (as opposed to right atrial placement). We did not observe poorer survival or increased sepsis in catheters replaced over a guidewire, and would advocate this technique as a means of salvage in this group of patients. (C) 1997 by the National Kidney Foundation, Inc.